A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This study is examining safety and immunogenicity of 2 doses of Trumenba administered on a 0-,6- month schedule. This trial is also studying safety and immunogenicity of a meningococcal pentavalent vaccine.
Epistemonikos ID: 65712c346f4d69b4bdf72ab1f97acd9aeb087f5e
First added on: May 20, 2024